NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
02/05/2023
Voltar para busca
Dado oficial do USPTO
NAVIGATION DRUG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NAVIGATION DRUG
ST13
US500000079309391Classe
1, 5, 44
Pedido
79309391
Registro
6720814
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
02/05/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 44
Data de depósito
21/12/2020
Data de registro
24/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/05/2022
Última transação
28/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Sapporo-shi, Hokkaido, JP
Examinador
FALK,JONATHAN ROBERT
Unidade examinadora
M20
Localização atual
TMO LAW OFFICE 111
Titulares e representantes
Titulares
Goryo Chemical, Inc.
Representantes
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for research purposes; reagents for chemical analyses other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents for scientific or research use; diagnostic reagents and preparationsexcept for medical or veterinary use; chemicalschemicals used in industrysulfonateschemicals for use in agricultureexcept fungicidesherbicidesinsecticides and parasiticides
Classe 5
Pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of breastbraincolorectal and gastro-intestinal cancer; pharmaceutical preparations and substances used for detecting body fluids; pharmaceutical preparations and substances used for detecting pancreatic fluids; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of cancer; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of digestive system disorders; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of bone diseases; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of hyperlipidemia diseases; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of gastrointestinal diseases; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of hypoglycemia; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of sarcoma; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of immune system diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of hypertension; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of respiratory diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of skin disorders; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of multiple sclerosis; pharmaceutical preparations and substances for the diagnosis and treatmentthe prevention of cardiovascular diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating central nervous system disorders; diagnostic biomarker reagents for medical purposes; veterinary diagnostic reagents; fluorescent diagnostic reagents for veterinary purposes; fluorescent diagnostic test reagents for veterinary purposes; diagnostic test reagents for medical purposes; fluorescent diagnostic test reagents for medical purposes; fluorescent diagnostic reagents for medical purposes; pharmaceutical preparations and other preparations for destroying verminfungicidesherbicides; fluorescent medical diagnostic reagents; chemical reagents for veterinary purposes; fluorescent chemical reagents for veterinary purposes; chemical reagents for medical purposes; fluorescent chemical reagents for medical purposes; reagents for medical purposes; fluorescent reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and analysis samples for testing of body fluids; medical fluorescent diagnostic reagents and assays for testing of body fluids; medical fluorescent diagnostic reagents and analysis samples for testing of body fluids; medical clinical diagnostic reagents; fluorescent reagents for the clinical diagnosis; therapeutic drugs and agentsagents for the treatment of malignant tumors
Classe 44
Medical testing services using fluorescent reagents for diagnostic or treatment purposes; medical analysis services for the analysisdiagnosistreatment of patients using fluorescent reagents provided by medical laboratories; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical evaluation of breastbraincolorectal and gastro-intestinal cancer; medical diagnostic services using fluorescent reagents; medical evaluation services of breastbraincolorectal and gastro-intestinal cancer using fluorescent reagents; diagnosis of diseases; diagnosis of diseases using fluorescent reagents; diagnosis of cancer; diagnosis of cancer using fluorescent reagents; medical testing services relating to the diagnosis and treatment of disease; medical testing services relating to the diagnosis and treatment of disease using fluorescent reagents; medical analysis services relating to the diagnosis and treatment of disease using fluorescent reagents provided by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis of cancer; cancer screening services; cancer screening services using fluorescent reagents; medical services for the analysis of samples taken from patients provided by medical laboratories; fluorescence imaging examination for the medical diagnosis or treatment; providing information in the field of cancer preventionscreeningdiagnosis and treatment; providing medical information; providing medical information on diagnosis using fluorescent reagents; providing information on medical diagnosis using fluorescent reagents; medical analysis for the diagnosis of cancer using fluorescent reagents; rental of medical apparatus and installations; rental of medical diagnostic apparatus and installations; rental of medical diagnostic apparatus using fluorescent reagents and medical apparatus and installations using fluorescent reagents
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/03/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
28/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/03/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/09/2022
FIMP
FINAL DISPOSITION PROCESSED
13/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/08/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/07/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
24/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/02/2022
PUBO
PUBLISHED FOR OPPOSITION
22/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
20/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/01/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
13/01/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
13/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/12/2021
RFNT
REFUSAL PROCESSED BY IB
01/08/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/07/2021
RFRR
REFUSAL PROCESSED BY MPU
12/07/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/07/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/06/2021
CNRT
NON-FINAL ACTION WRITTEN
24/06/2021
DOCK
ASSIGNED TO EXAMINER
16/06/2021
MAFR
APPLICATION FILING RECEIPT MAILED
27/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/04/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/04/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NAVIGATION DRUG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.